Skip to Content Facebook Feature Image

Realsee Empowers FIDOVN to Revolutionize Vietnam's Real Estate Industry Through VR

Business

Realsee Empowers FIDOVN to Revolutionize Vietnam's Real Estate Industry Through VR
Business

Business

Realsee Empowers FIDOVN to Revolutionize Vietnam's Real Estate Industry Through VR

2025-04-23 17:07 Last Updated At:17:25

Technology Reconstructs the Human Habitat

BEIJING, April 23, 2025 /PRNewswire/ -- When Vietnamese homebuyers wander through three-dimensional property listings in the cloud via VR, and multinational enterprises complete cross-border talent recruitment through virtual reality, FIDOVN—a tech-driven real estate platform deeply rooted in the Vietnamese market—is redefining " Work smart - Life chill " with disruptive technology. Currently, FIDOVN has established Southeast Asia's first VR+AI+Data Hub OMO ecosystem, leveraging digital infrastructure to drive transformative change in a trillion-dollar market in the post-pandemic era. Behind this innovation lies the product and technical prowess of Realsee, a leading tech company providing digital space integrated solutions.

With world-class 3D reconstruction capabilities and a comprehensive hardware-software product portfolio, Realsee has empowered FIDOVN to elevate its service offerings:

Centered on Realsee's self-developed professional Galois 3D LiDAR Camera

and the lightweight Realsee G1 Smart Phone Gimbal, FIDOVN has digitized over 10,000 real estate units. Galois is the industry's first fixed-location laser scanner deployed at scale globally, while the Realsee G1 device enables full spatial replication using only a smartphone. Realsee's advanced editing systems and software suite allow users to annotate, measure, and enhance 3D models while embedding features like navigation, synchronized co-browsing, AI-guided tours, and instant communication. This "what-you-see-is-what-you-get" experience accelerates decision-making, shortening the property transaction cycle. FIDOVN data reveals a 37% VR-driven conversion rate—triple the industry average.

Powered by Realsee's technology, FIDOVN established Southeast Asia's first VR+AI+Data Hub OMO ecosystem, seamlessly integrates online VR tour, virtual interviews, and cloud-based contracts with offline community service hubs covering southern Vietnam's core regions, enabling 30-minute rapid transactions. This dual empowerment for B2B and B2C users has generated a million-level behavioral data asset. According to Ho Chi Minh City's Real Estate Association, agencies adopting VR reduced customer acquisition costs by 45%, while 93% of Gen Z buyers prioritize VR experience when selecting agents (per FIDOVN surveys).

An expat engineer in Binh Duong Province remotely selected a Ho Chi Minh City luxury apartment via AI-driven family-structure recommendations, finalizing cross-border ownership at a local hub. A Vietnamese HR director at a Chinese multinational boosted interview rates by 58% through VR scenarios. "These are real FIDOVN success stories where Realsee's VR technology delivers tangible value," stated Matthew Zhao, FIDOVN's founder.

While most firms optimize workflows with technology, FIDOVN—through Realsee's VR—is reimagining human-space interactions: from VR tour to digital workplaces, smart communities to democratized tech access. In the era of digital-real economy convergence, Realsee's solutions serve as inclusive infrastructure, empowering FIDOVN to make Work smart - Life chill.

FIDOVN marks a pivotal step in Realsee's global expansion. Moving forward, Realsee will continue advancing spatial digitization through technological innovation, delivering future-ready solutions to partners in Vietnam and beyond—unlocking infinite possibilities for intelligent, interconnected spaces.

About Realsee

As a leading tech company providing digital space integrated solutions, Realsee has built the world's largest 3D spatial database by replicating physical spaces, covering over 47 million spaces and boasting over 590 global authorized patents.

Realsee offers digital solutions for your space, spanning from its design and construction stage, to online marketing and visual operation.

Trust Realsee to elevate your real estate transactions, commercial retail, industrial facilities, cultural exhibitions, public affairs, and home decor to the next level.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Realsee Empowers FIDOVN to Revolutionize Vietnam's Real Estate Industry Through VR

Realsee Empowers FIDOVN to Revolutionize Vietnam's Real Estate Industry Through VR

AUCKLAND, New Zealand, May 2, 2025 /PRNewswire/ -- Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence.

There are now over 100 peer-reviewed studies describing the efficacy of the company's proprietary AROA ECM technology.

AROA's most recent publication was a large retrospective analysis of real-world evidence (RWE) from wound care centers in the US, assessing the efficacy of the company's Endoform NaturalTM product in treating venous leg ulcers (VLUs), in comparison to a leading reconstituted collagen dressing.

VLU's are open sores that are hard-to-heal because of impaired blood flow and can be very debilitating and painful.  These types of wounds are difficult for clinicians to treat successfully. For example, only ~40% of VLUs can be healed after 3 months of treatment and there is a relatively high chance that these wounds will recur[1].

The peer-reviewed study, entitled "Clinical Efficacy of Ovine Forestomach Matrix and Collagen/Oxidized Regenerated Cellulose for the Treatment of Venous Leg Ulcers: A Retrospective Comparative Real-World Evidence Study" was published in the open access journal 'International Wound Journal in April 2025.

The study compared 470 VLU's that had been treated with Endoform Natural to 360 VLU's that had been treated with a reconstituted collagen product. The study used existing data from 223 wound care centers with minimal inclusion or exclusion criteria so that 'real-world' use of both products could be compared.

"There is a growing awareness of RWE studies to validate clinical performance" says Chief Scientific Officer, Dr. Barnaby May. "These types of studies enable much larger patient numbers to be compared versus traditional randomized controlled trials. Given that RWE studies use data from 'real-world' use of a treatment, the results can be more meaningful, especially in wound care where there is a high degree of variability in how wounds are cared for and patient factors."

The study found that VLUs treated with Endoform Natural healed up to ~ 8 weeks faster versus the comparator group, and the chances of the wound healing were significantly improved when Endoform Natural was used as part of treatment.

The striking difference in the healing outcomes demonstrate the potential for considerable cost reductions and improvements in patient quality of life, due to the significant improvements seen when VLUs were treated using Endoform Natural.

Dr. Gregory Bohn MD was part of the research team. "I was first introduced to Endoform in 2012 and started using the product to treat my own patients with VLUs. This new data validates what I have seen in my own practice managing VLUs with Endoform."

This is the second large retrospective RWE comparing Endoform Natural to a leading reconstituted collagen dressing. A previous study included the analysis of over 2,200 diabetic foot ulcers (DFUs) and also demonstrated significantly faster healing of DFUs using Endoform Natural[2].

The study is available online here.

[1] Kolluri R, Lugli M, Villalba L, Varcoe R, Maleti O, Gallardo F, et al. An estimate of the economic burden of venous leg ulcers associated with deep venous disease. Vasc Med. 2022;27(1):63-72.

[2] Bosque BA, Frampton C, Chaffin AE, Bohn GA, Woo K, DeLeonardis C, Lepow BD, Melin MM, Madu T, Dowling SG, May BCH. Retrospective real-world comparative effectiveness of ovine forestomach matrix and collagen/ORC in the treatment of diabetic foot ulcers. Int Wound J. 2022 May;19(4):741-753.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.

AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.

Recommended Articles
Hot · Posts